Argenx's Vyvgart sales rose in the second quarter
23/07/2026 06:08
Argenx's Vyvgart sales rose in the second quarter July 23 (Reuters) - Belgian-Dutch immunology company argenx ARGX.BR said on Thursday global product sales of its lead drug Vyvgart rose in the second quarter of 2026 from a year earlier.
(Reporting by Lucie Barbier; Editing by Kate Mayberry)
((Email: lucie.barbier@thomsonreuters.com))